APA (7th ed.) Citation

Gulley, J. L., Emens, L. A., Hwu, P., Bifulco, C. B., Ohashi, P. S., Moussion, C., & Feltquate, D. (2025). SITC perspective: Leveraging patient enrichment biomarkers to accelerate early phase IO drug development. BMJ Publishing Group.

Chicago Style (17th ed.) Citation

Gulley, James L., Leisha A. Emens, Patrick Hwu, Carlo B. Bifulco, Pamela S. Ohashi, Christine Moussion, and David Feltquate. SITC Perspective: Leveraging Patient Enrichment Biomarkers to Accelerate Early Phase IO Drug Development. BMJ Publishing Group, 2025.

MLA (9th ed.) Citation

Gulley, James L., et al. SITC Perspective: Leveraging Patient Enrichment Biomarkers to Accelerate Early Phase IO Drug Development. BMJ Publishing Group, 2025.